Dr. Francine Touzard Romo, MD

Dr. Touzard Romo practices at The Miriam Hospital in Providence, Rhode Island, part of Brown University Health.

Dr. Touzard Romo's NPI, 1104072214, was assigned on August 8, 2008. Dr. Touzard Romo holds Rhode Island license MD13968.

Dr. Touzard Romo's primary practice is The Miriam Hospital, at 164 Summit Avenue, Providence, RI 02906 in Providence County. The practice phone is (401) 793-2500.

Dr. Touzard Romo's primary practice is The Miriam Hospital in Providence, Rhode Island, part of Brown University Health. Dr. Touzard Romo is also affiliated with Rhode Island Hospital. The medical group on file is Brown Health Medical Group. Dmand AI also links Dr. Touzard Romo to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Touzard Romo practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Touzard Romo's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Touzard Romo is board certified in infectious disease by the American Board of Internal Medicine. Dr. Touzard Romo is licensed in Rhode Island.

CMS data shows 154 Medicare services from Dr. Touzard Romo across 5 procedure codes in 2024, for 79 Medicare patients. Medicare paid $14,273 for them.

CMS counts 79 Medicare patients who saw Dr. Touzard Romo in 2024. The largest group is 75 to 84, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Touzard Romo's median patient age at 71, with 33% women.

In 2024, Dr. Touzard Romo wrote 684 Medicare Part D claims for 54 patients. 61% of them were for generic drugs. CMS names the drug for 493 of them, across 18 drugs with 11 or more claims each, at $858,540 in total drug cost. In 2023, CMS named 343 claims across 12 drugs.

Dr. Touzard Romo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Touzard Romo, published from 2014 to 2024. 2014 was the busiest year, with 2. The most frequent topics are HIV Infections, Ambulatory Care and Anti-HIV Agents. Dr. Touzard Romo has published most often in R I Med J (2013). Dr. Touzard Romo's most frequent co-authors are Curt G. Beckwith, MD, Timothy P. Flanigan, MD and Erna M. Kojic, MD.

CMS Open Payments shows 1 general payment to Dr. Touzard Romo from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. CorMedix Inc. paid the most, $18.